TEAM

Chief Executive Officer

 Surgical Oncologist and biotechnology investor. Adrian leads Strandwise’s clinical and strategic vision, ensuring that autonomous discovery translates into real-world oncology diagnostics and therapeutics. He is also CEO of a biotechnology-focused hedge fund, bringing deep expertise in evaluating, financing, and scaling high-impact biomedical innovation at the intersection of science, medicine, and capital. 

Chief Operating Officer

 Chemical Engineer and operations leader with extensive experience scaling complex technical organizations from early-stage ventures through enterprise environments. Sean oversees execution, infrastructure, and operational scalability at Strandwise, translating advanced scientific programs into manufacturable, regulatory-ready systems. His expertise spans product development, manufacturing strategy, cross-functional leadership, and large-scale transformation. 

Nanotechnology

 Professor at Texas State University and Principal Investigator of the Printed Electronics Lab. Dr. Chen is an internationally published expert in nanomaterials, printed electronics, and advanced device fabrication. At Strandwise, she leads nanotechnology strategy supporting high-sensitivity biosensing architectures and next-generation diagnostic platforms. 

Biosensor Designer

 Biosensor systems designer specializing in the integration of biological interfaces, materials engineering, and signal transduction. Sean leads the design and development of Strandwise’s biosensor platforms, translating biological detection requirements into robust, scalable sensing technologies compatible with clinical workflows. 

Quantum Software

 Software developer focused on building reliable, scalable computational systems. Javier develops the software infrastructure that supports Strandwise’s discovery platform, data pipelines, and analytical tooling, enabling seamless integration between autonomous intelligence, simulation, and experimental workflows.